Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
CHANGES IN IMMUNOLOGICAL VARIABLES (TNF-A, SCD8 AND SCD4) DURING DANAZAL TREATMENT IN PATIENTS WITH ENDOMETRIOSIS
Autore:
MATALLIOTAKIS I; NEONAKI M; ZOLINDAKI A; HASSAN E; GEORGOULIAS V; KOUMANTAKIS E;
Indirizzi:
7 GIANNIKOU STR IRAKLION CRETE GREECE UNIV HOSP,DEPT OBSTET & GYNECOL IRAKLION CRETE GREECE
Titolo Testata:
International journal of fertility and women's medicine
fascicolo: 3, volume: 42, anno: 1997,
pagine: 211 - 214
SICI:
1534-892X(1997)42:3<211:CIIV
Fonte:
ISI
Lingua:
ENG
Soggetto:
INFERTILE PATIENTS; PERITONEAL-FLUID; WOMEN;
Keywords:
DANAZOL; ENDOMETRIOSIS; SCD4; SCD8; TNF-A (TUMOR NECROSIS FACTOR);
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Science Citation Index Expanded
Citazioni:
19
Recensione:
Indirizzi per estratti:
Citazione:
I. Matalliotakis et al., "CHANGES IN IMMUNOLOGICAL VARIABLES (TNF-A, SCD8 AND SCD4) DURING DANAZAL TREATMENT IN PATIENTS WITH ENDOMETRIOSIS", International journal of fertility and women's medicine, 42(3), 1997, pp. 211-214

Abstract

Design-The levels of TNF-a, sCD8, and sCD4 were measured in serum samples taken from 20 women. Blood samples for TNF-a, sCD8 and sCD4 levels were taken from 10 endometriotic women before treatment, during the last 15 days of a 6-month administration of danazol and 3 months aftertreatment. Blood samples were taken only once from 10 women without endometriosis (control group). Results-TNF-a levels were higher in women with endometriosis before treatment compared to controls (P < .05). Administration of the drug significantly reduced the levels of TNF-a (P < .01) and sCD8 (P < .001). Conclusion-This study indicates that danazol significantly reduces endometriosis-associated autoimmune abnormalities.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 21/01/20 alle ore 00:58:38